The Catalonian Royal Academy of Medicine is an advisory body to healthcare and justice authorities, promotes studies on the history of Catalonian medicine and organises conferences and debates. It has 60 fellows, who are elected by the fellows themselves, 15 honorary fellows, 120 national members by election or award and ordinary members, whose numbers are not limited and among which the three specialists from IMO can be found.
As part of the membership procedure, Dr García-Arumí read the paper "Diabetic retinopathy: its treatment and future challenges" in a special session held on 29 March at the Catalonian Royal Academy of Medicine in Barcelona. During his presentation, IMO specialist recalled that "diabetes is currently considered the most common cause of blindness among the working population in the industrialised world and accounts for between 20 and 30% of all cases of total blindness." In addition, he outlined the main advances in the treatment of the disease, such as laser photocoagulation or intraocular injections of medication, as well as improvements in surgical and diagnostic techniques. The ophthalmologist stated that "future challenges in the treatment of diabetic retinopathy include genetic detection of patients with a risk of proliferation and the use of protective molecules, on which work is already being carried out."
Clinical, research and teaching work
Dr José García-Arumí is a founding member of IMO and, since January 2011, has been chairman of the newly created Fundacion IMO, which is dedicated to basic research in ophthalmology. IMO specialist also teaches 4th-year medical students and postgraduate students (ophthalmology house officers and ophthalmologists preparing their doctoral theses) at the Universitat Autònoma in Barcelona, where he has been a professor since 2007. In addition, he is a senior lecturer and founding member of the European School for Advanced Studies in Ophthalmology.